FULCRUM THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
FULCRUM THERAPEUTICS, INC. (FULC) had Lessee, Operating Lease, Liability, to be Paid, Year One of $2.42 million as of 2021-12-31, per its 10-K/A filed 2023-06-26.
Discontinued › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2023-06-26
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.42M.
- 2021-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.42M.
- 2021-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.42M.
- 2021-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.42M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2021-12-31 | $2.42M 10-K/A · filed 2023-06-26 |
| 2021-09-30 | $2.42M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.42M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $2.42M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.35M 10-K/A · filed 2023-06-23 |
| 2020-09-30 | $2.35M 10-Q · filed 2020-11-10 |
| 2019-12-31 | $2.29M 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |